Christopher Beck
Operationeel Directeur bij CONTEXT THERAPEUTICS INC.
Profiel
Christopher Beck is a professional with experience in various pharmaceutical companies.
He is currently working as Senior Vice President-Operations at Context Therapeutics, Inc. Prior to this, he worked as Vice President-Program Management at Galera Therapeutics, Aevi Genomic Medicine, and Formular Pharmaceuticals.
He completed his undergraduate degree at Drexel University and earned an MBA from The Pennsylvania State University.
Actieve functies van Christopher Beck
| Bedrijven | Functie | Begin |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Operationeel Directeur | 05-01-2022 |
Eerdere bekende functies van Christopher Beck
| Bedrijven | Functie | Einde |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
| Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Christopher Beck
| Drexel University | Undergraduate Degree |
| The Pennsylvania State University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| CONTEXT THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Formular Pharmaceuticals, Inc. |
